Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Several factors contribute to these elevated costs: Patent protection Most GLP-1 medications are still under patent, preventing generic competition Manufacturing complexity These are biologic medications that require specialized production processes Research and development costs Pharmaceutical companies invest heavily in clinical trials and regulatory approval Market positioning These medications are often priced as premium treatments Without insurance coverage, patients face the full retail price, which can make these medications financially inaccessible for many people who need them
Every missed dose of oral medication creates a gap in therapeutic coverage that does not occur as readily with weekly injectable dosing
Kenealy and Terasawa, 2011)
The former two groups are infective to mammals while the latter two affect birds
Coronavirus Disease 2019 (COVID-19)
US$ 25.52
US$ 24.86
US$ 25.86
US$ 25.69
US$ 21.40
